Granules India gets USFDA approval for ANDA; stock surges Granules India gets USFDA approval for ANDA; stock surges Apurva Joshi / Friday, April 24, 2020 / Article rating: 4.7 Granules India has received US Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA), Trospium Chloride extended-release capsules, 60 mg.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low DSIJ Intelligence / Friday, April 24, 2020 / Article rating: 3.6 The market opened in the red on April 24, 2020. The previous trading session witnessed the Sensex going up by 1.54 percent to end at 31,863 and the Nifty was up 1.4 percent to close at 9,313.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high DSIJ Intelligence / Friday, April 24, 2020 / Article rating: 4.3 The market opened in the red on April 24, 2020. The previous trading session witnessed the Sensex going up by 1.54 percent to end at 31,863 and the Nifty was up 1.4 percent to close at 9,313.
Five stocks with selling interest Five stocks with selling interest DSIJ Intelligence / Friday, April 24, 2020 / Article rating: 4.6 The market opened in the red on April 24, 2020, overall volumes in futures & options currently stand at 4,31 crore contracts with a turnover of Rs. 21,07,936.09 crore.
Five stocks with buying interest Five stocks with buying interest DSIJ Intelligence / Friday, April 24, 2020 / Article rating: 4.5 The market opened in the red on April 24, 2020, overall volumes in futures & options currently stand at 4,31 crore contracts with a turnover of Rs. 21,07,936.09 crore.
Larsen & Toubro receives order from DFCCIL Larsen & Toubro receives order from DFCCIL Amir Shaikh / Friday, April 24, 2020 / Article rating: 3.9 Railways Strategic Business Unit of L&T Construction’s Transportation Infrastructure IC in consortium with Kyosan Electric Manufacturing Co Ltd (Japan) has received a significant order in the form of three packages from Dedicated Freight Corridor Corporation of India Limited
Shilpa Medicare launches generic anticancer drug Dasatinib Shilpa Medicare launches generic anticancer drug Dasatinib Apurva Joshi / Friday, April 24, 2020 / Article rating: 3.5 Shilpa Medicare Limited has informed the bourses that it has launched Indian branded generic of Dasatinib, an anticancer drug with a brand name ‘Dasashil’. The drug substance patent on Dasatinib was owned by Bristol-Myers-Squibb and had expired on April 12, 2020.
Franklin Templeton India shuts down six debt funds Franklin Templeton India shuts down six debt funds DSIJ Intelligence / Friday, April 24, 2020 / Article rating: 3.3 One of India's oldest fund houses is winding up its six debt funds. Read on to find how it will impact its investors.
‘MCap to sales ratio gives valuation comfort ‘MCap to sales ratio gives valuation comfort Pratik Shastri / Friday, April 24, 2020 / Article rating: 3.4 Further, the data also shows that FMCG companies trade at a much higher valuation than that of their sales. Like, Hindustan Unilever, Dabur India and Emami get up to eight times more valuations in comparison to their sales.
Soft start in offing Soft start in offing DSIJ Intelligence / Friday, April 24, 2020 / Article rating: 4.5 Indian markets might witness a soft start but an important event of the day is that Prime Minister Narendra Modi is likely to meet Finance Minister Nirmala Sitharaman to finalise a second stimulus package. The market participants will be all eyes & ears to this event as it could dictate the future trend of the market.